- Heart of Genetic Counseling Award recognizing
excellence in patient care will be presented by Invitae and NSGC
-
SAN
FRANCISCO, Nov. 10, 2022 /PRNewswire/
-- Researchers from Invitae (NYSE: NVTA), a leading
medical genetics company, are presenting research next week at the
National Society of Genetic Counselors (NSGC) 41st Annual
Conference in Nashville enabling
the progress of the science and practice of genetics in patient
care. In addition to its research presentations, the company will
present the Heart of Genetic Counseling Award, which recognizes
excellence in the field of genetic counseling.
![Invitae's (NVTA) mission is to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. www.invitae.com (PRNewsFoto/Invitae Corporation) Invitae's (NVTA) mission is to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. www.invitae.com (PRNewsFoto/Invitae Corporation)](https://mma.prnewswire.com/media/268592/invitae_corporation_logo.jpg)
The company's research presentations, which include a
pre-conference symposium, opening plenary, sponsored session and
poster presentations, add to both the science and practice of the
fast-growing field of medical genetics. Among the company's poster
presentations is a retrospective case-control study aimed to assess
the cancer risk for individuals who have a monoallelic MUTYH
pathogenic/likely pathogenic variant. In addition, Invitae will
present a study highlighting how RNA sequencing can help classify
variants predicted to alter RNA splicing, as well as uncovering
splice-altering variants in regions outside of the standard
reportable range of targeted DNA panels.
"The NSGC annual meeting is a great opportunity for Invitae to
show our continued commitment to genetic counselors and their
patients as well as furthering the science behind genetic testing,"
said Robert Nussbaum, M.D., chief
medical officer at Invitae. "Working with genetic counselors, we
continue to champion affordability, accessibility and innovation –
so that we can find answers for more patients, together."
Heart of Genetic Counseling Award
In addition to the research presentations at the meeting,
Invitae and NSGC will present the 2022 Heart of Genetic Counseling
Award in a ceremony at the NSGC Annual Conference. The Heart of
Genetic Counseling Award was established to honor excellence in
genetic counseling patient care as recognized by patients
themselves. Nominations include stories from patients that
highlight both the clinical and personal impact a genetic counselor
had on their lives and the lives of their families. The finalists
include:
- Monisha Sebastin, MS,
CGC, Children's Hospital at Montefiore Medical Center, The
Bronx, New York, was nominated by
a parent whose daughter has fanconi anemia (FA), a rare genetic
disease that affects the bone marrow. When the daughter was
diagnosed with COVID, Sebastin went above and beyond to get her
treatment by arranging for her infusions within a few hours which
was critical given the daughter's pulmonary issues and compromised
immune system.
- Victoria Vincent, MS,
CGC, University of South Carolina,
Columbia, South Carolina, showed
true compassion for a patient who lost several children due to
surfactant protein-B (SP-B) deficiency, a rare lung disorder that
causes most babies to die within the first few weeks of life.
Vincent provided the patient with emotional support during her
losses and, after many years, celebrated with the patient when they
discovered that her son and his fiancée did not carry the SP-B
mutation.
- Julianne Wojciak, MS,
LGC, University of California, San Francisco,
California, counseled a patient during her testing for the
LMNA genetic mutation, which can cause cardiac arrest or heart
failure. Due to the diagnosis, the patient received an internal
cardiac monitor, which detected pauses in her heart activity that
saved her life. Wojciak also supported the patient through the
process of testing her children for the LMNA mutation.
The Heart of Genetic Counseling Award will be presented on
Thursday, November 17.
Full presentation schedule
The full schedule of the Invitae presentations at the conference
is as follows:
Wednesday, November 16
- Pre-conference symposium. REAssessing the Use of Race,
Ethnicity, Ancestry (REA) Information in Genomic Medicine. |
Presented by: Robert Nussbaum, M.D.,
Invitae. | 12 - 5:30 p.m. CST
Thursday, November 17
- Opening Plenary. We're not in Kansas anymore, Toto! International Genetic
Counselors' Experiences in the U.S. | Presented by: Rachel Mador, MS, CGC, Invitae. | 9:15 - 10 a.m. CST
- Heart of Genetic Counseling Award Presentation | Presented by:
Invitae and NSGC. | 7:30 - 9:30 p.m.
CST
Friday, November 18
- Industry sponsored session. How clinical experts and artificial
intelligence work together in an effort to improve genetic testing
results. | Presented by: Molly
Stetler, MS, CGC, and Sarah
Klemm, MS, CGC, Invitae. | 12:30 -
1:45 p.m. CST
Virtual, on demand for registered attendees
- Poster. Increased colorectal cancer risk among monoallelic
MUTYH founder variant carriers tested at a commercial laboratory |
Presented by: Brandie Heald Leach,
MS, CGC, Invitae
- Poster. Combined DNA and RNA analysis of hereditary cancer
associated genes: More answers for more patients | Presented by:
Daniel Pineda, M.D., Invitae
About Invitae
Invitae Corporation (NYSE: NVTA) is a
leading medical genetics company, whose mission is to bring
comprehensive genetic information into mainstream medicine to
improve healthcare for billions of people. Invitae's goal is to
aggregate the world's genetic tests into a single service with
higher quality, faster turnaround time and lower prices. For more
information, visit the company's website at invitae.com.
Safe Harbor Statement
This press release
contains forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995, including
statements relating to the benefits and impact of the company's
research and collaborations; the potential and importance of
genetic testing and genetic counseling services; and the progress
of the science and practice of genetics in patient care.
Forward-looking statements are subject to risks and uncertainties
that could cause actual results to differ materially, and reported
results should not be considered as an indication of future
performance. These risks and uncertainties include, but are not
limited to: the company's history of losses; the company's ability
to compete; the company's failure to manage growth effectively; the
company's need to scale its infrastructure in advance of demand for
its tests and to increase demand for its tests; the company's
ability to use rapidly changing genetic data to interpret test
results accurately and consistently; security breaches, loss of
data and other disruptions; laws and regulations applicable to the
company's business; and the other risks set forth in the company's
filings with the Securities and Exchange Commission, including the
risks set forth in the company's Quarterly Report on Form 10-Q for
the quarter ended September 30, 2022.
These forward-looking statements speak only as of the date hereof,
and Invitae Corporation disclaims any obligation to
update these forward-looking statements.
Contact:
Amanda McQuery
pr@invitae.com
(628) 213-3283
View original content to download
multimedia:https://www.prnewswire.com/news-releases/invitae-showcases-advances-in-medical-genomics-at-the-national-society-of-genetic-counselors-nsgc-41st-annual-conference-301674637.html
SOURCE Invitae Corporation